Back to results
US 11,999,729 B2Granted
Small molecule inhibition of transcription factor SALL4 and uses thereof
AssigneesDana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
InventorsJun Qi, Anthony Varca, Li Chai
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.
Claims22
A compound having a structure of Formula I or a pharmaceutically acceptable salt thereof:
- wherein
- Z is N;
- R1 is optionally substituted C5 or C6-cycloalkyl, optionally substituted heterocyclyl, naphthalenyl substituted with one or more groups selected from hydroxyl and nitro,
- optionally substituted oxazolyl, optionally substituted benzoisoxazolyl, optionally substituted indazolyl, optionally substituted azaindolyl, optionally substituted benzothiazolyl, optionally substituted thiazolyl, or optionally substituted carbazolyl;
- and
- R2 is optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocyclyl, optionally substituted aryl, or optionally substituted heteroaryl.
3 more elements
A compound which is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.